McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers... Show more
MCK saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 02, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved above the 0 level on July 07, 2025. You may want to consider a long position or call options on MCK as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
MCK moved above its 50-day moving average on July 03, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MCK advanced for three days, in of 380 cases, the price rose further within the following month. The odds of a continued upward trend are .
MCK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 287 cases where MCK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.892). P/E Ratio (24.254) is within average values for comparable stocks, (29.460). Projected Growth (PEG Ratio) (5.107) is also within normal values, averaging (4.521). Dividend Yield (0.004) settles around the average of (0.032) among similar stocks. P/S Ratio (0.241) is also within normal values, averaging (35.215).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a distributer of pharmaceuticals and provides healthcare software and health information technology services
Industry MedicalDistributors
A.I.dvisor indicates that over the last year, MCK has been loosely correlated with COR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MCK jumps, then COR could also see price increases.
Ticker / NAME | Correlation To MCK | 1D Price Change % | ||
---|---|---|---|---|
MCK | 100% | +0.43% | ||
COR - MCK | 66% Loosely correlated | +0.71% | ||
CAH - MCK | 49% Loosely correlated | -0.12% | ||
SHTDF - MCK | 9% Poorly correlated | N/A | ||
OMI - MCK | 8% Poorly correlated | -4.00% | ||
ZYXI - MCK | 3% Poorly correlated | -1.65% | ||
More |